Research Grants
Funding For:
Value-based Precision Medicine: Assessing the Financial Implications of Medicare’s Coverage Policy for Advanced Genetic Testing
Health Care Management / Cost & Quality / Health Care Coverage
Recipient:
So-Yeon Kang, Georgetown University School of Health and Lombardi Comprehensive Cancer Center
Grant Period:
Jan 01, 2025 - Dec 31, 2025
AMOUNT:
$50,049.00
Summary of the Project:
In recent years, the number of genomically targeted therapies and genetic tests has grown significantly, with advances in precision medicine driving notable improvements in patient outcomes and drug safety. This study will assess the shift from single-gene testing to next-generation sequencing (NGS), a more advanced and comprehensive form of genomic testing, and explore the potential value associated with adopting this technology, particularly in terms of healthcare spending. Additionally, the team will also analyze the relationship between NGS-related insurance outcomes and Medicare’s national coverage policy for NGS.